Aquestive Therapeutics, Inc. AQST Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s operating lease liabilities?
- Aquestive Therapeutics, Inc. (AQST) reported operating lease liabilities of $4.16M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Aquestive Therapeutics, Inc.'s operating lease liabilities decreased by 13.7% year-over-year, from $4.82M to $4.16M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s operating lease liabilities has grown at a 8.8% compound annual growth rate (CAGR), from $2.85M to $4.34M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.